Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 112(7): 2917-26, 2008 Oct 01.
Article in English | MEDLINE | ID: mdl-18641367

ABSTRACT

The histone deacetylase inhibitor SAHA enhances cell death stimulated by the proteasome inhibitor bortezomib (BZ) by disrupting BZ-induced aggresome formation. Here we report that Myc regulates the sensitivity of multiple myeloma (MM) cells to BZ + SAHA-induced cell death. In MM cells, Myc expression directly correlated with intracellular ER content, protein synthesis rates, the percentage of aggresome-positive cells, and the sensitivity to BZ + SAHA-induced cell death. Accordingly, Myc knockdown markedly reduced the sensitivity of MM cells to BZ + SAHA-mediated apoptosis. Furthermore, activation of Myc was sufficient to provoke aggresome formation and thus sensitivity to BZ + SAHA, and these responses required de novo protein synthesis. BZ + SAHA-mediated stimulation of apoptosis includes the induction of the proapoptotic BH3-only protein Noxa as well as endoplasmic reticular stress, a disruption of calcium homeostasis, and activation of capase-4. Finally, knockdown studies demonstrated that both caspase-4 and Noxa play significant roles in Myc-driven sensitivity to BZ + SAHA-induced apoptosis. Collectively, our results establish a mechanistic link between Myc activity, regulation of protein synthesis, increases in HDAC6 expression and aggresome formation, induction of Noxa, and sensitivity to BZ + SAHA-induced apoptosis. These data suggest that MM patients with elevated Myc activity may be particularly sensitive to the BZ + SAHA combination.


Subject(s)
Apoptosis/drug effects , Boronic Acids/pharmacology , Cell Nucleus Structures/drug effects , Cell Nucleus Structures/metabolism , Hydroxamic Acids/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Pyrazines/pharmacology , Bortezomib , Cell Line, Tumor , Cell Nucleus Structures/ultrastructure , Cycloheximide/pharmacology , Diploidy , Drug Synergism , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/pathology , Endoplasmic Reticulum/ultrastructure , Fibroblasts/drug effects , Fibroblasts/pathology , Histone Deacetylase 6 , Histone Deacetylases/metabolism , Humans , Multiple Myeloma/pathology , Protein Biosynthesis/drug effects , RNA, Small Interfering/metabolism , Vorinostat
SELECTION OF CITATIONS
SEARCH DETAIL
...